Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-002766

Chief Operating Officer sold 1,021 shares at $23.32 ($23,810)

From the SEC's structured data for this filing

Trades in this filing

ADAMS R MARK · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-07 Sale : show line 1 in the form −1,021 $23.32 $23,810 50,833 D
Open-market sales · 1,021 sh · avg $23.32 · $23,810
Loading xslF345X03/doc4.xml…